期刊文献+

结肠癌组织中Sp3与ABCG2的表达相关性及临床意义

Correlation between Sp3 and ABCG2 expression in colon carcinoma tissues and its clinical significance
原文传递
导出
摘要 目的探究特异性蛋白3(Sp3)与三磷酸腺苷结合蛋白G亚族成员2(ABCG2)在人结肠癌组织中的表达及其相关性,并探讨其临床意义。方法收集2010年1月1日至2015年1月1日普通外科行外科手术治疗的50例患者的结肠癌组织及对应癌旁组织,采用免疫组化染色检测Sp3和ABCG2蛋白在组织中的表达,采用Spearman相关性分析两种蛋白在结肠癌组织中表达的相关性,分析肿瘤组织中Sp3和ABCG2蛋白表达的临床意义。结果Sp3和ABCG2蛋白均高表达于结肠癌组织中,其阳性表达率分别为50.0%和66.0%,明显高于癌旁组织中Sp3(20.0%)和ABCG2蛋白(26.0%)阳性表达率(P均<0.01)。临床资料分析发现,有淋巴结转移及TNM分期(Ⅲ+Ⅳ期)的结肠癌组织中Sp3及ABCG2蛋白阳性表达率明显高于无淋巴结转移和Ⅰ+Ⅱ期的结肠癌组织(P<0.01,P<0.05);相关性分析表明,Sp3和ABCG2蛋白在结肠癌组织中的表达呈显著正相关关系(r=0.801,P<0.01)。结论结肠癌组织中Sp3和ABCG2蛋白表达上调,且与患者恶性临床特征相关,二者表达的正相关关系提示在结肠癌中ABCG2可能是Sp3的转录靶点之一。 Objective To investigate correlation between expressions of specificity protein 3( Sp3) and ATP-binding cassette sub-family G member 2( ABCG2) in colon carcinoma tissues and their correlation and explore the clinical significance. Methods The colon carcinoma tissues and the matched tumor adjacent tissues samples from 50 patients receiving surgical operation between January 1,2010 and January 1,2015 were collected. Immunohistochemistry staining method was used to detect the expressions of Sp3 and ABCG2 proteins in the tissues. Spearman correlation analysis was used to analyze the relationship between these two proteins expressions in colon carcinoma tissues and the clinical significance of Sp3 and ABCG2 proteins expressions in colon carcinoma tissues. Results Both Sp3 and ABCG2 proteins were highly expressed in colon carcinoma tissues,and the positive expression rates of Sp3( 50. 0%) and ABCG2( 66. 0%) in colon carcinoma tissues were significantly higher than those( 20. 0%,26. 0%) in tumor adjacent tissues( all P〈0. 01). The clinical data analysis showed that the positive expression rates of Sp3 and ABCG2 proteins in colon carcinoma tissues with lymph node metastasis and TNM staging of III + IV stages were significantly higher than those without lymph node metastasis and with TNM staging of I + II stages( P〈0. 01,P〈0. 05). The correlation analysis showed that the expressions of Sp3 and ABCG2 proteins in colon carcinoma tissues presented significant positive correlation( r = 0. 801,P〈0. 01). Conclusions The expressions of Sp3 and ABCG2 proteins in colon carcinoma tissues are up-regulated and associated with patients' malignant clinic features. The positive correlation of Sp3 and ABCG2 expressions prompts that ABCG2 may be one of transcriptional targets of Sp3.
作者 陶红光 宗华
出处 《中国临床研究》 CAS 2016年第8期1026-1029,共4页 Chinese Journal of Clinical Research
关键词 特异性蛋白3 三磷酸腺苷结合蛋白G亚族成员2 结肠癌 表达 相关性 Specificity protein 3 ATP-binding cassette sub-family G member 2 Colon carcinoma Expression Correlation
  • 相关文献

参考文献17

  • 1Feng L,Yao HP,Wang W,et al. Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel ther- apeutics for targeted colorectal cancer therapy [ J ]. Clin Cancer Res, 2014,20 ( 23 ) :6045 - 6058.
  • 2Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003- 2005 : a population - based study [ J ]. Int J Cancer, 2015,136 ( 8 ) : 1921 - 1930.
  • 3Hofman J, Ku~3era R, Neumanova Z, et al. Placental passage of olo- moucine 1I, but not purvalanol A, is affected by p-glycoprotein (ABCBI), breast cancer resistance protein ( ABCG2 ) and multi- drug resistance-associated proteins (ABCCs) [ J ]. Xenobiotica, 2016,46(5 ) :416 -423.
  • 4Wang S, Li F, Quan E, et al. Efflux transport characterization of res- veratrol glucuronides in UDP-glucuronosyhransferase 1 A1 transfected heLa cells:application of a cellular phammcokinetic model to deci- pher the contribution of muhidrug resistance-associated protein 4 [ J ]. Drug netab Dispos ,2016,44 (4) :485 - 488.
  • 5Sun Y,Gu M,Zhu L, et al. Gemcitabine upregulates ABCG2/BCRP and modulates the intracellular pharmacokinetic profiles of biolumi- nescence in pancreatic cancer cells [ J ]. Anticancer Drugs,2016,27 (3) :183 -191.
  • 6Yang WJ, Song M J, Park EY, et al. Transcription factors Spl and Sp3 regulate expression of human ABCG2 gene and chemoresistance phe- notype [ J]. Mol Cells,2013,36 (4) :368 - 375.
  • 7Zhang X, Xu J, Liu H, et al. Predictive bionmrkers for the efficacy of the cetuximab combined with cisplatin and capecitabine in advanced gastric or esophagogastric junction adenocarcinoma: a prospective multicenter phase 2 trial [ J ]. Med Oncol,2014,31 ( 10 ) :226.
  • 8Han K,Jin J,Maia M, et al. Lower exposure and faster clearance of bevacizunmb in gastric cancer and the impact of patient variables : a- nalysis of individual data from AVAGAST phase III trial [ J ]. AAPS J,2014,16(5) :1056 - 1063.
  • 9Poulsen L~, Qvortrup C, Pfeiffer P, et al. Review on adjuvant chemo- therapy for rectal cancer-why do treatment guidelines differ so much? [J]. Acta Oneol,2015,54(4) :437 -446.
  • 10程浩,贾喜花,张晓伟,张金库.胃癌组织ABCG2和P-gp蛋白表达及其临床意义分析[J].中华肿瘤防治杂志,2013,20(4):273-277. 被引量:11

二级参考文献38

  • 1张爱民,胡佑伦.胃癌耐药基因的表达及其在药物适配个体化治疗中的意义[J].中华实验外科杂志,2004,21(12):1485-1487. 被引量:10
  • 2Hu L,McArthur C,Jaffe RB. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant[J]. Br J Cancer,2010,102(8):1276-1283.
  • 3Shi H, Lu D, Shu Y, et al. Expression of muhidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-Ⅱ and lung resistance protein in primary gastric cardiac adenocarcinoma[J]. Cancer Invest, 2008,26 (4) : 344-351.
  • 4Cusatis G,Sparreboom A. Pharmacogenomic importance of AB- CG2[J]. Pharmacogenomics, 2008,9 (8) .. 1005-1009.
  • 5Sun N, Sun X,Chen B, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer[J]. Cancer Chemother Pharmacol, 2010,65 (3) : 437-446.
  • 6Kiyotani K, Mushiroda T, Imamura CK, et al. Significant effect of polymorphisms in CYP2D6 and ABCG2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients[J]. J Clin Oncol,2010,28(8):1287-1293.
  • 7Hu M, To KK, Mak VW, et al. The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid- lowering effects of statins[J]. Expert Opin Drug Metab Toxicol, 2011,7(1):49-62.
  • 8Bleau AM, Huse JT, Holland EC. The ABCG2 resistance network of glioblastoma[J]. Cell Cycle,2009,8(18) :2936-2944.
  • 9Pfister O, Oikonomopoulos A, Sereti KI, et al. Role of the ATP- binding cassette transporter Abeg2 in the phenotype and function of cardiac side population cells[J]. Circ Res, 2008,103 (8) : 825- 835.
  • 10Chen Z, Liu F, Ren Q, et al. Suppression of ABCG2 inhibits cancer cell proliferation[J]. Int J Cancer, 2010,126(4) : 841-851.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部